Systemic Lupus Erythematosus

Slides:



Advertisements
Similar presentations
PERSISTENT KNEE SWELLING IN A LUPUS PATIENT Pediatric Rheumatology Case Dr. Christine Bernal IIIB-4.
Advertisements

Lupus in Pregnancy Darren Farley, MD Clinical Assistant Professor
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
(SLE).  Definition  Epidemiology  Pathophysiology  Clinical features  Classification and diagnosis  Treatment  Prognosis  Lupus related syndromes.
SLE Systemic Lupus Erythematosus. Systemic lupus erythematosus (disseminated lupus erythematosus, lupus) is a chronic inflammatory connective tissue.
1 IN THE NAME OF GOD. 2 SYSTEMIC LUPUS ERYTHEMATOSIS (SLE)
Systemic Lupus Erythematosus in children. Objectives Student will be able to define Lupus Student will be able list at least 3 clinical manifestation.
Get Into the Loop – Learn About Lupus
LUPUS IN MEN. SLE: IMMUNOLOGIC FACTORS HALLMARK: POLYCLONAL IMMUNE HYPERACTIVITY WITH INCREASED PRODUCTION OF ANTIBODIES AGAINST “SELF” CONSTITUENTS.
Autoimmune Diseases Dr. Raid Jastania. Autoimmune Diseases Group of diseases with common pathological process Presence of auto-antibody ?defect in B-cells.
Systemic Lupus Erythematosus
Gender Differences in Immune Response Females resist a variety of infections better than males ??? Females may reject transplanted organs more rapidly.
Dr. Meg-angela Christi Amores
Systemic Lupus Erythematosus
Focus on Systemic Lupus Erythematosus (SLE)
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division under the supervision and administration.
Systemic Lupus Erythematosis. The Immune System Immunology Connection to Tissue Engineering Develop methods to selectively block immune response to engineered.
No history of arthritis Significant cardiomegaly on chest x-ray
Oct. 14 There is no evidence of bowel obstruction or dilatation. 1. Extensive axillary, mediastinal, abdominal, pelvic lymphadenopathy, as above, most.
Systemic Lupus Erythematosus (SLE) Cheryl McConnell RN, MSN.
Image From collection/systemic_lupus_erythematosus_1_picture/pict ure.htm.
Systemic Lupus Erythematosus. Systemic Lupus Erythematosus (SLE) Multisystemic inflammatory chronic disease characterized by inflammation of blood vessels.
Naomi Sen.  Aim ◦ To give an outline of the diagnosis and management of SLE  Objectives ◦ To describe signs and symptoms of SLE ◦ To outline relevant.
Systemic Lupus Erythematosus. Intended Learning Objectives (ILOs) Identify definition and causes of SLE.Identify definition and causes of SLE. Understand.
DR: DRGEHAN MOHAMED DR. GEHAN MOHAMED Systemic Lupus Erythermatosus(SLE)
Autoimmune disease -a disruption in the function of the immune system of the body, resulting in the production of antibodies against the body's own cells.
Systemic lupus erythematosus (SLE) is an autoimmune disease in which organs and cells undergo damage mediated by tissue- binding autoantibodies and immune.
Secondary glomerular diseases typical case reports morphology Doc. MUDr. Zdeňka Vernerová, CSc., MUDr. Martin Havrda.
SLE systeimic lupus erythematosisi  Prof Dr Muzamil Shahzad.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Morning Report August 4, 2009.
SLE is an autoimmune disease of unknown etiology, characterized by acute& chronic inflammation of various tissues of the body. Autoimmune diseases are.
September 24,  20% diagnosed in childhood  Mostly in adolescence  F:M ratio  Prior to puberty - 3:1  After puberty - 9:1  Native Americans.
Lupus Nephritis Prof. Hafiz Ijaz Ahmad Department of Nephrology Allama Iqbal Medical College Lahore.
By: Rian Asmeida Farha binti Ahmad Rejab Wan Fadhilah binti Wan Ibrahim S YSTEMIC L UPUS E RYTHEMATOSUS (SLE)
SYSTEMIC LUPUS ERYTHEMATOSIS BY Dr. Hayam Hebah Associate professor of internal medicine AL-Maarefa College.
Mixed Connective Tissue Disease
Systemic Lupus Erythematosus
Lupus!! (Yay!!!…..???). Goals Outline The Basics Emergency Stuff –Presenting symptoms –Complications –Infection Quizzes… with prizes!
Systemic Lupus Erythematosus Angelique Davis Q: Why does seal have scars on his face? A: Discoid Lupus.
ANA Testing Carrie Marshall 1/18/08 1.
Systemic Lupus Erythemetosus Kantemirova M.G.. Systemic Lupus Erythematosus (SLE) Butterfly Rash, mouth ulcers, lupus-hyalites.
Introduction to collagen-vascular diseases. Definition: Rheumatologic (or Rheumatic) Disease: diseases characterized by pain and inflammation in joints.
Systemic Lupus Erythematosus 류마티스내과 R3 신재령. Introduction  SLE 소개  Lupus nephritis  Antiphospholipid Syndrome.
Fever of unknown source: Cases Family Medicine Specialist CME October 15-17, 2012 Pakse.
Systemic Lupus Erythematosus (SLE). SLE Lupus is the latin word for “WOLF” Is an autoimmune disorder characterized by inflammation of almost any body.
Dr Huberta Quartey , Padiki Narh , Dr Ida Dey.
Decoding your Lupus labs: What do all those letters mean?
Autoimmune Disorders During Pregnancy -Lupus -Antiphospholipid syndrome Rovnat Babazade, MD Obstetrical Anesthesia-2016.
Systemic lupus erythematosus
Management of SLE.
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) BY DR WAQAR MBBS, MRCP ASST. PROFESSOR.
 Henoch-Schonlein Purpura
“Mixed Connective Tissue Disease: Still Crazy After All These Years”
Systemic Lupus Erythematosis
Systemic Lupus Erythematosus
IMMUNITY II.
Henoch–Schönlein Purpura (HEN-awk SHURN-line PUR-pu-ruh)
Lupus Erythematosus Paige Ramsett.
Management of SLE.
Sytemic Lupus Erythematosus
Henoch-Schönlein Purpura. WHAT IS Henoch-Schönlein Purpura  Also called anaphylactoid purpura  Henoch-Schönlein purpura (HSP) is the most common form.
Nephrology cases Dr . Hayam Hebah.
SYSTEMIC LUPUS ERYTHEMATOSIS
Acute / Chronic Glomerulonephritis
Advanced Adult Health Ashanti Starr Johnson, BSN, RN
Lupus By: Brittni McClellan.
Presentation transcript:

Systemic Lupus Erythematosus

Synonyms and related keywords: SLE, autoimmune disease, lupus nephritis, atherosclerosis, nephritis, antiphospholipid syndrome,

Background: Systemic lupus erythematosus (SLE) is an autoimmune disease involving multiple organ systems that is defined clinically and associated with antibodies directed against cell nuclei.

Pathophysiology: Autoantibodies, circulating immune complexes, and T lymphocytes all contribute to the expression of disease. Organ systems affected include dermatologic, renal, central nervous system (CNS), hematologic, musculoskeletal, cardiovascular, pulmonary, the vascular endothelium, and gastrointestinal.

Criteria for SLE Malar rash Discoid rash Photosensitivity Oral ulcers Arthritis Serositis Renal disorder Neurologic disorder Hematologic disorder Immunologic disorder Antinuclear antibody

Mortality/Morbidity: Early deaths usually are caused by active disease. Atherosclerosis is a leading cause in late deaths. Infection and nephritis are major causes of mortality in all stages of SLE. After dialysis or transplantation, a reduction in disease activity and flares has been reported. Thrombosis, often secondary to antiphospholipid syndrome, carditis, pneumonitis, pulmonary hypertension, stroke, myocardial infarction, and cerebritis cause severe morbidity and mortality.

Sex: Ninety percent of cases are in women. Also, women who are exposed to estrogen-containing oral contraceptives or hormone replacement have an increased risk of developing SLE.

History: The disease is characterized by exacerbations and remissions. Many women relate flares of their lupus to the postovulatory phase of the menstrual cycle, with resolution of symptoms at the time of menses.

Systemic symptoms include a low-grade fever, fatigue, malaise, anorexia, nausea, and weight loss. Initial presentation may involve one or more organ systems. Arthralgias (53-95%) are the initial complaint in many patients. Often, the pain is out of proportion to physical findings. Malar, butterfly rash over the cheeks and bridge of the nose (55-90%) with photosensitivity to ultraviolet (UV) light has been reported (mostly in whites). It also often involves the chin and ears. Painful or painless ulcers in the nose and mouth are frequent complaints. CNS symptoms may range from mild cognitive dysfunction to a history of seizures (12-59%).

Psychiatric symptoms (high-dose steroids also can cause psychosis [5-37%]) - If the psychosis gets worse after stopping the steroid, it is most likely related to the disease process. Pleuritic pain (31-57%), dyspnea, cough, fever, and chest pain are important cardiopulmonary complaints. Patients may present with abdominal pain, diarrhea, and vomiting. Intestinal perforation and vasculitis are important diagnoses to exclude.

Physical: Fever is a challenging problem in SLE. Malar rash is a fixed erythema sparing the nasolabial folds. It is a butterfly rash that can be flat or raised over the cheeks and bridge of the nose. It also often involves the chin and ears. Discoid rash occurs in 20% of patients with SLE and can be disfiguring secondary to scarring. It presents as erythematous patches with keratotic scaling over sun-exposed areas of the skin and may occur in the absence of any systemic manifestations. All patients experience painless or painful oral or vaginal ulcers at some time in their illness. Gastrointestinal findings include vague abdominal discomfort, nausea, and diarrhea. Acute crampy abdominal pain, vomiting, and diarrhea may signify vasculitis of the intestine.

Joint findings Tenderness, edema, and effusions accompany polyarthritis that is symmetric, nonerosive, and usually nondeforming. It frequently involves the proximal interphalangeal (PIP) and metacarpophalangeal (MCP) joints of the hands, as well as the wrists and knees. Consider avascular necrosis, which is common in patients receiving glucocorticoids. Also consider septic arthritis when one joint is inflamed out of proportion to all other joints.

Renal system - Specific signs and symptoms of renal disease may not be apparent until advanced nephrotic syndrome or renal failure is present; therefore, obtaining a urine analysis and serum BUN and creatinine levels on a regular basis is important. Cardiovascular system findings Atherosclerosis occurs prematurely in patients with SLE Pulmonary hypertension, vasculitis with digital infarcts, and splinter hemorrhages may be observed. Systolic murmurs are reported in up to 70% of cases. Pericarditis has an incidence of 20-30% and is the most common presentation of heart involvement.

Drug-induced lupus Before making a diagnosis of SLE, ruling out drugs as the cause of the condition is important. Procainamide, hydralazine, and isoniazid have been studied the best. Also Chlorpromazine,Methyldopa, Isoniazid Quinidine.

Lab Studies: Antinuclear antibody (ANA), an antibody to nucleosomal DNA-histone complexes, is more than 95% sensitive but not very specific. Anti–double-stranded DNA is more specific for lupus. This test may correlate with the degree of activity of lupus, in general, and with the level of nephritis. Rarely should autoantibody tests be ordered in the ED, unless that is done for the assistance of a secured rheumatology follow-up. Complete blood count (CBC) + ESR Leukopenia, which generally is a good index for disease activity Lymphopenia Anemia of chronic disease (60-80%) Evidence of a hemolytic anemia (10%) Cytotoxic therapy (can cause anemia or leukopenia) Thrombocytopenia (30-50% of cases),

Blood urea (BU) and creatinine Antiphospholipid antibody partial thromboplastin time (PTT) may be elevated secondary to lupus anticoagulant (antiphospholipid antibody). Urinalysis Pyuria Hematuria Granular casts Proteinuria Blood urea (BU) and creatinine Antiphospholipid antibody

Imaging Studies: Chest radiographs Effusion Infiltrates Cardiomegaly echocardiogram may be indicated to evaluate any effusion causing pericardial pain Magnetic resonance imaging (MRI) is most useful for assessing brain pathology. Computed tomography (CT) is useful to rule out bleeding or mass lesions.

TREATMENT Conservative management with nonsteroidal anti-inflammatory drugs including salicylates is recommended for arthritis, arthralgias, and myalgias not requiring immunosuppression. Only initiate high-dose glucocorticoids and cytotoxic agents by, or in consultation with, a rheumatologist. Patients with thrombosis require anticoagulation with warfarin for a target international normalized ratio (INR) of 3-3.5. Antibiotics may be appropriate in the treatment of ordinary and opportunistic infections.

Complications: Vasculitis and its various complications (eg, intestinal perforations) Pericarditis Myocarditis Lupus pneumonitis Pulmonary hemorrhage, pulmonary hypertension Proliferative glomerulonephritis Hemolytic anemia, thrombocytopenia Intravascular thrombosis (eg, stroke and myocardial infarctions) Complications of high dose glucocorticoid therapy Complications of cytotoxic agents

Prognosis: Prognosis has improved over the last few years. Mortality typically is due to renal failure or infection.